Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | APAF1 | O14727 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | XBP1 | P17861 | 1/20 | 0.41 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | GALK1 | P51570 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PDK2 | Q15119 | 6/20 | 0.35 |
| ▸ | BACE1 | P56817 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19764705 | 0.87 | BACE1 (0.43) | MEN1LMNAMAPTKMT2ASMN1; SMN2 | |
| SCHEMBL19764690 | 0.86 | PDK2 (0.41) | MEN1LMNAMAPTKMT2ASMN1; SMN2 | |
| SCHEMBL23697261 | 0.81 | GABRG2 (0.37) | MEN1MAPTKMT2ASMN1; SMN2NPC1 | |
| SCHEMBL19764704 | 0.81 | PDK2 (0.34) | MEN1LMNAMAPTKMT2ASMN1; SMN2 | |
| SCHEMBL19764707 | 0.80 | MEN1 (0.41) | MEN1LMNAMAPTKMT2ASMN1; SMN2 | |
| SCHEMBL25854806 | 0.78 | TYMS (0.36) | MEN1LMNAMAPTKMT2ASMN1; SMN2 | |
| SCHEMBL25854804 | 0.78 | TYMS (0.36) | MEN1LMNAMAPTKMT2ASMN1; SMN2 | |
| SCHEMBL28267231 | 0.78 | NOX1 (0.41) | MEN1LMNAMAPTKMT2ASMN1; SMN2 | |
| SCHEMBL12166381 | 0.77 | L3MBTL1 (0.35) | MEN1LMNAMAPTKMT2AATM | |
| SCHEMBL19764691 | 0.77 | ALDH1A1 (0.34) | MEN1LMNAMAPTKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10566547-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-02-18 | — | — | US | disclosed |
| US-20180013074-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10566547-B2 | Organic electroluminescent materials and devices | PAX2, EYA2, NLRP1 | MEN1 2810/4885LMNA 2691/4885MAPT 2328/4885 |
| US-20180013074-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PAX2, EYA2, NLRP1 | MEN1 2810/4885LMNA 2691/4885MAPT 2328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.